Skip to main content
Top
Published in: Radiation Oncology 1/2011

Open Access 01-12-2011 | Research

Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning

Authors: Lucia Perna, Cesare Cozzarini, Eleonora Maggiulli, Gianni Fellin, Tiziana Rancati, Riccardo Valdagni, Vittorio Vavassori, Sergio Villa, Claudio Fiorino

Published in: Radiation Oncology | Issue 1/2011

Login to get access

Abstract

Several investigations have recently suggested the existence of a correlation between the dose received by the penile bulb (PB) and the risk of erectile dysfunction (ED) after radical radiotherapy for clinically localized prostate carcinoma.
A prospective multi-Institute study (DUE-01) was implemented with the aim to assess the predictive parameters of ED. Previously, an evaluation of inter-observer variations of PB contouring was mandatory in order to quantify its impact on PB dose-volume parameters by means of a dummy run exercise.
Fifteen observers, from different Institutes, drew the PB on the planning CT images of ten patients; inter-observer variations were analysed in terms of PB volume variation and cranial/caudal limits. 3DCRT treatment plans were simulated to evaluate the impact of PB contouring inter-variability on dose-volume statistics parameters. For DVH analysis the values of PB mean dose and the volume of PB receiving more than 50 Gy and 70 Gy (V50 and V70, respectively) were considered. Systematic differences from the average values were assessed by the Wilcoxon test.
Seven observers systematically overestimated or underestimated the PB volume with deviations from the average volumes ranging between -48% and +34% (p < 0.05). The analysis of the cranial and caudal borders showed a prevalence of random over systematic deviations.
Inter-observer contouring variability strongly impacts on DVH parameters, although standard deviations of inter-patient differences were larger than inter-observer variations: 14.5 Gy versus 6.8 Gy for mean PB dose, 23.0% versus 11.0% and 16.8% versus 9.3% for V50 and V70 respectively.
In conclusion, despite the large inter-observer variation in contouring PB, a large multi-centric study may have the possibility to detect a possible correlation between PB % dose-volume parameters and ED. The impact of contouring uncertainty could be reduced by "a posteriori" contouring from a single observer or by introducing Magnetic Resonance Imaging (MRI) in the planning procedures and/or in improving the skill of observers through post-dummy run tutoring of those observers showing large systematic deviations from the mean.
Appendix
Available only for authorised users
Literature
1.
go back to reference Incrocci L, Slob AK, Levenday PC: Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys 2002, 52: 681-693. 10.1016/S0360-3016(01)02727-4CrossRefPubMed Incrocci L, Slob AK, Levenday PC: Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys 2002, 52: 681-693. 10.1016/S0360-3016(01)02727-4CrossRefPubMed
2.
go back to reference Incrocci L: Sexual function after external-beam radiotherapy for prostate cancer: what do we know? Oncol Hematol 2006, 57: 165-173. Incrocci L: Sexual function after external-beam radiotherapy for prostate cancer: what do we know? Oncol Hematol 2006, 57: 165-173.
3.
go back to reference Incrocci L: Changes in sexual function after treatment of male cancer. JMHG 2005, 2: 236-243. Incrocci L: Changes in sexual function after treatment of male cancer. JMHG 2005, 2: 236-243.
4.
go back to reference Incrocci L: Erectile dysfunction and radiation therapy for prostate cancer. Sexologies 2006, 15: 116-120. 10.1016/j.sexol.2006.03.005CrossRef Incrocci L: Erectile dysfunction and radiation therapy for prostate cancer. Sexologies 2006, 15: 116-120. 10.1016/j.sexol.2006.03.005CrossRef
5.
go back to reference Robinson JW, Moritz S, Fung T: Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002, 54: 1063-1068. 10.1016/S0360-3016(02)03030-4CrossRefPubMed Robinson JW, Moritz S, Fung T: Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002, 54: 1063-1068. 10.1016/S0360-3016(02)03030-4CrossRefPubMed
6.
go back to reference Roach M III, Chinn DM, Holland J, et al.: A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1996, 35: 869-874. 10.1016/0360-3016(96)00206-4CrossRefPubMed Roach M III, Chinn DM, Holland J, et al.: A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1996, 35: 869-874. 10.1016/0360-3016(96)00206-4CrossRefPubMed
7.
go back to reference Crook J, Esche B, Futter N: Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology 1996, 54: 124-129. Crook J, Esche B, Futter N: Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology 1996, 54: 124-129.
8.
go back to reference Nguyen L, Pollack A, Zagars GK: Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 1998, 51: 991-997. 10.1016/S0090-4295(98)00028-4CrossRefPubMed Nguyen L, Pollack A, Zagars GK: Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 1998, 51: 991-997. 10.1016/S0090-4295(98)00028-4CrossRefPubMed
9.
go back to reference Zelefsky MJ, Leibel SA, Gaudin PB, et al.: Dose escalation with threedimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998, 41: 491-500. 10.1016/S0360-3016(98)00091-1CrossRefPubMed Zelefsky MJ, Leibel SA, Gaudin PB, et al.: Dose escalation with threedimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998, 41: 491-500. 10.1016/S0360-3016(98)00091-1CrossRefPubMed
10.
go back to reference Borghede G, Hedelin H: Radiotherapy of localized prostate cancer. Analysis of late treatment complications. A prospective study. Radiother Oncol 1997, 43: 139-146. 10.1016/S0167-8140(96)01871-3CrossRefPubMed Borghede G, Hedelin H: Radiotherapy of localized prostate cancer. Analysis of late treatment complications. A prospective study. Radiother Oncol 1997, 43: 139-146. 10.1016/S0167-8140(96)01871-3CrossRefPubMed
11.
go back to reference Turner SL, Adams K, Bull CA, et al.: Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology 1999, 54: 124-129. 10.1016/S0090-4295(99)00032-1CrossRefPubMed Turner SL, Adams K, Bull CA, et al.: Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology 1999, 54: 124-129. 10.1016/S0090-4295(99)00032-1CrossRefPubMed
12.
go back to reference Johannes CB, Araujo AB, Feldman HA, et al.: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000, 163: 460-463. 10.1016/S0022-5347(05)67900-1CrossRefPubMed Johannes CB, Araujo AB, Feldman HA, et al.: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000, 163: 460-463. 10.1016/S0022-5347(05)67900-1CrossRefPubMed
13.
go back to reference Goldstein I, Feldman MI, Deckers PJ, et al.: Radiation-associated impotence. A clinical study of its mechanism. Jama 1984, 251: 903-910. 10.1001/jama.251.7.903CrossRefPubMed Goldstein I, Feldman MI, Deckers PJ, et al.: Radiation-associated impotence. A clinical study of its mechanism. Jama 1984, 251: 903-910. 10.1001/jama.251.7.903CrossRefPubMed
14.
go back to reference Siegel T, Moul JW, Spevak M, et al.: The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001, 165: 1582-1592. Siegel T, Moul JW, Spevak M, et al.: The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001, 165: 1582-1592.
15.
go back to reference Pickett B, Fisch BM, Weinberg V, et al.: Dose to the bulb of the penis is associated with the risk of impotence following radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45: 263.CrossRef Pickett B, Fisch BM, Weinberg V, et al.: Dose to the bulb of the penis is associated with the risk of impotence following radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45: 263.CrossRef
16.
go back to reference Merrick GS, Butler WM, Wallner KE, et al.: The importance of radiation doses to the penile bulb vs. crura in the development of post brachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 2002, 54: 1055-1062. 10.1016/S0360-3016(02)03031-6CrossRefPubMed Merrick GS, Butler WM, Wallner KE, et al.: The importance of radiation doses to the penile bulb vs. crura in the development of post brachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 2002, 54: 1055-1062. 10.1016/S0360-3016(02)03031-6CrossRefPubMed
17.
go back to reference Kitelet RA, Lee WR, deGuzman AF, et al.: Radiation dose to neurovascula bundles of penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy 2002, 1: 90-94. 10.1016/S1538-4721(02)00018-1CrossRef Kitelet RA, Lee WR, deGuzman AF, et al.: Radiation dose to neurovascula bundles of penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy 2002, 1: 90-94. 10.1016/S1538-4721(02)00018-1CrossRef
18.
go back to reference Zelefsky MJ, Eid JF: Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 1998, 40: 129-133. 10.1016/S0360-3016(97)00554-3CrossRefPubMed Zelefsky MJ, Eid JF: Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 1998, 40: 129-133. 10.1016/S0360-3016(97)00554-3CrossRefPubMed
19.
go back to reference Mittal B: A study of penile circulation before and after radiation in patients with prostate cancer and its effect on impotence. Int J Radiat Oncol Biol Phys 1985, 11: 11-21. Mittal B: A study of penile circulation before and after radiation in patients with prostate cancer and its effect on impotence. Int J Radiat Oncol Biol Phys 1985, 11: 11-21.
20.
go back to reference Mulhall JP, Yonover P, Sethi A, et al.: Radiation exposure to the corporeal bodies during 3 dimensional conformal radiotherapy for prostate cancer. J Urol 2002, 167: 539-542. 10.1016/S0022-5347(01)69081-5CrossRefPubMed Mulhall JP, Yonover P, Sethi A, et al.: Radiation exposure to the corporeal bodies during 3 dimensional conformal radiotherapy for prostate cancer. J Urol 2002, 167: 539-542. 10.1016/S0022-5347(01)69081-5CrossRefPubMed
21.
go back to reference Mulhall JP, Yonover P: Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer [Letter]. Urology 2002, 58: 828.CrossRef Mulhall JP, Yonover P: Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer [Letter]. Urology 2002, 58: 828.CrossRef
22.
go back to reference Robinson JW, Moritz S, Fung T: Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002, 54: 1063-1068. 10.1016/S0360-3016(02)03030-4CrossRefPubMed Robinson JW, Moritz S, Fung T: Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 2002, 54: 1063-1068. 10.1016/S0360-3016(02)03030-4CrossRefPubMed
23.
go back to reference Fisch BM, Pickett B, Weinberg V, et al.: Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology 2001, 57: 955-959. 10.1016/S0090-4295(01)00940-2CrossRefPubMed Fisch BM, Pickett B, Weinberg V, et al.: Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology 2001, 57: 955-959. 10.1016/S0090-4295(01)00940-2CrossRefPubMed
24.
go back to reference Roach M, Winter K, Michalski JM, et al.: Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 2004, 60: 1351-1356. 10.1016/j.ijrobp.2004.05.026CrossRefPubMed Roach M, Winter K, Michalski JM, et al.: Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 2004, 60: 1351-1356. 10.1016/j.ijrobp.2004.05.026CrossRefPubMed
25.
go back to reference Mangar SA, Sydes MR, Tucker HL, et al.: Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer. Radiother Oncol 2006, 80: 355-362. 10.1016/j.radonc.2006.07.037CrossRefPubMed Mangar SA, Sydes MR, Tucker HL, et al.: Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer. Radiother Oncol 2006, 80: 355-362. 10.1016/j.radonc.2006.07.037CrossRefPubMed
26.
go back to reference Wernicke AG, Valicenti R, DiEva K, et al.: Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after threedimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004, 60: 1357-1363. 10.1016/j.ijrobp.2004.05.030CrossRefPubMed Wernicke AG, Valicenti R, DiEva K, et al.: Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after threedimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004, 60: 1357-1363. 10.1016/j.ijrobp.2004.05.030CrossRefPubMed
27.
go back to reference Selek U, Cheng R, Lii M, et al.: Erectile dysfunction and radiation dose to the penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys 2004, 59: 1039-1046. 10.1016/j.ijrobp.2003.12.028CrossRefPubMed Selek U, Cheng R, Lii M, et al.: Erectile dysfunction and radiation dose to the penile base structures: a lack of correlation. Int J Radiat Oncol Biol Phys 2004, 59: 1039-1046. 10.1016/j.ijrobp.2003.12.028CrossRefPubMed
28.
go back to reference Sethi A, Mohideen N, Leybovich L, Mulhall J: Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys 2003, 55: 970-978. 10.1016/S0360-3016(02)04164-0CrossRefPubMed Sethi A, Mohideen N, Leybovich L, Mulhall J: Role of IMRT in reducing penile doses in dose escalation for prostate cancer. Int J Radiat Oncol Biol Phys 2003, 55: 970-978. 10.1016/S0360-3016(02)04164-0CrossRefPubMed
29.
go back to reference Kao J, Turian J, Meyers A, Hamilton RJ, Smith B, Vijayakumar S, et al.: Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer. Br J Radiol 2004, 77: 129-136. 10.1259/bjr/37893924CrossRefPubMed Kao J, Turian J, Meyers A, Hamilton RJ, Smith B, Vijayakumar S, et al.: Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer. Br J Radiol 2004, 77: 129-136. 10.1259/bjr/37893924CrossRefPubMed
30.
go back to reference Young CD, Speight JL, Akazawa PF, Pickett B, Verhey LJ, Roach M: Improved conformal coverage of the prostate with an IMRT potency-sparing technique. Int J Radiat Oncol Biol Phys 2000, 48: 351.CrossRef Young CD, Speight JL, Akazawa PF, Pickett B, Verhey LJ, Roach M: Improved conformal coverage of the prostate with an IMRT potency-sparing technique. Int J Radiat Oncol Biol Phys 2000, 48: 351.CrossRef
31.
go back to reference Perna L, Fiorino C, Cozzarini C, et al.: Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy. Radiother Oncol 2009, 93: 57-63. 10.1016/j.radonc.2009.04.004CrossRefPubMed Perna L, Fiorino C, Cozzarini C, et al.: Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy. Radiother Oncol 2009, 93: 57-63. 10.1016/j.radonc.2009.04.004CrossRefPubMed
32.
go back to reference Van der Wielen GJ, Mulhall JP, Incrocci L: Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 2007, 84: 107-113. 10.1016/j.radonc.2007.07.018CrossRefPubMed Van der Wielen GJ, Mulhall JP, Incrocci L: Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 2007, 84: 107-113. 10.1016/j.radonc.2007.07.018CrossRefPubMed
33.
go back to reference Fiorino C, Valdagni R, Rancati T, Sanguineti G: Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol 2009, 93: 153-167. 10.1016/j.radonc.2009.08.004CrossRefPubMed Fiorino C, Valdagni R, Rancati T, Sanguineti G: Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol 2009, 93: 153-167. 10.1016/j.radonc.2009.08.004CrossRefPubMed
34.
go back to reference Roach M, Nam J, Gagliardi G, et al.: Radiation dose-volume effects and the penile bulb. Int J Radiat Oncol Biol Phys 2010, 76: S130-S134. 10.1016/j.ijrobp.2009.04.094CrossRefPubMed Roach M, Nam J, Gagliardi G, et al.: Radiation dose-volume effects and the penile bulb. Int J Radiat Oncol Biol Phys 2010, 76: S130-S134. 10.1016/j.ijrobp.2009.04.094CrossRefPubMed
35.
go back to reference Debois M, Oyen N, Maes F, et al.: The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45: 857-865. 10.1016/S0360-3016(99)00288-6CrossRefPubMed Debois M, Oyen N, Maes F, et al.: The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999, 45: 857-865. 10.1016/S0360-3016(99)00288-6CrossRefPubMed
36.
go back to reference Rasch C, Barillot I, Remeijer P, et al.: Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999, 43: 57-66. 10.1016/S0360-3016(98)00351-4CrossRefPubMed Rasch C, Barillot I, Remeijer P, et al.: Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999, 43: 57-66. 10.1016/S0360-3016(98)00351-4CrossRefPubMed
37.
go back to reference Milosevic M, Voruganti S, Blend R, et al.: Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and uretrography. Radiother Oncol 1998, 47: 277-284. 10.1016/S0167-8140(97)00232-6CrossRefPubMed Milosevic M, Voruganti S, Blend R, et al.: Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and uretrography. Radiother Oncol 1998, 47: 277-284. 10.1016/S0167-8140(97)00232-6CrossRefPubMed
38.
go back to reference Algan O, Hanks GE, Shaer AH: Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys 1995, 33: 925. 10.1016/0360-3016(95)00226-4CrossRefPubMed Algan O, Hanks GE, Shaer AH: Localization of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys 1995, 33: 925. 10.1016/0360-3016(95)00226-4CrossRefPubMed
39.
go back to reference Roach M III: Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency sparing radiotherapy? Int J Radiat Oncol Biol Phys 2005, 61: 1-2. 10.1016/j.ijrobp.2004.05.038CrossRefPubMed Roach M III: Is it time to change the standard of care from CT to MRI for defining the apex of the prostate to accomplish potency sparing radiotherapy? Int J Radiat Oncol Biol Phys 2005, 61: 1-2. 10.1016/j.ijrobp.2004.05.038CrossRefPubMed
40.
go back to reference Pickett B, Kurhanewicz J, Fein B, Coakley F, Shinohara K, Roach M: Use of magnetic resonance imaging and spectroscopy in the evaluation of external beam radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2003, 2: S163.CrossRef Pickett B, Kurhanewicz J, Fein B, Coakley F, Shinohara K, Roach M: Use of magnetic resonance imaging and spectroscopy in the evaluation of external beam radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2003, 2: S163.CrossRef
41.
go back to reference Rasch C, Remeijer P, Barillot I, van Herk M, Lebesque JV: Observer and imaging modality (CT, MRI) related definition of the prostate. Int J Radiat Oncol Biol Phys 1997, 2: S288.CrossRef Rasch C, Remeijer P, Barillot I, van Herk M, Lebesque JV: Observer and imaging modality (CT, MRI) related definition of the prostate. Int J Radiat Oncol Biol Phys 1997, 2: S288.CrossRef
42.
go back to reference Malone S, Crook J, Perry G, Broeders M, Salhani D, Gerig L, et al.: Effects of uretrography on prostate position: considerations for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 1997, 2: S288.CrossRef Malone S, Crook J, Perry G, Broeders M, Salhani D, Gerig L, et al.: Effects of uretrography on prostate position: considerations for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 1997, 2: S288.CrossRef
43.
go back to reference Akazawa PF, Roach M III, Malfatti C, Hrieak H: A comparison of the prostate volume defined by magnetic resonance imaging and computed tomographic (CT) scans during treatment for prostate cancer. Int J Radiat Oncol Biol Phys 1995, 152. Akazawa PF, Roach M III, Malfatti C, Hrieak H: A comparison of the prostate volume defined by magnetic resonance imaging and computed tomographic (CT) scans during treatment for prostate cancer. Int J Radiat Oncol Biol Phys 1995, 152.
44.
go back to reference McLaughlin P, Narayana V, Meirovitz A, et al.: Vessel-sparing prostate radiotherapy dose limitation to critical erectile vascular structures (internal pudental artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 2005, 61: 20-31. 10.1016/j.ijrobp.2004.04.070CrossRefPubMed McLaughlin P, Narayana V, Meirovitz A, et al.: Vessel-sparing prostate radiotherapy dose limitation to critical erectile vascular structures (internal pudental artery and corpus cavernosum) defined by MRI. Int J Radiat Oncol Biol Phys 2005, 61: 20-31. 10.1016/j.ijrobp.2004.04.070CrossRefPubMed
45.
go back to reference Wallner KE, Merrick GS, Benson ML, et al.: Penile bulb imaging. Int J Radiat Oncol Biol Phys 2002, 53: 928-933. 10.1016/S0360-3016(02)02805-5CrossRefPubMed Wallner KE, Merrick GS, Benson ML, et al.: Penile bulb imaging. Int J Radiat Oncol Biol Phys 2002, 53: 928-933. 10.1016/S0360-3016(02)02805-5CrossRefPubMed
46.
go back to reference Fiorino C, Reni M, Bolognesi A, et al.: Intra and inter-observer variability in contouring prostate and seminal vesicles: implication for conformal treatment planning. Radiother Oncol 1998, 47: 285-292. 10.1016/S0167-8140(98)00021-8CrossRefPubMed Fiorino C, Reni M, Bolognesi A, et al.: Intra and inter-observer variability in contouring prostate and seminal vesicles: implication for conformal treatment planning. Radiother Oncol 1998, 47: 285-292. 10.1016/S0167-8140(98)00021-8CrossRefPubMed
47.
go back to reference Fiorino C, Vavassori V, Sanguineti G, et al.: Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability. Radiother and Oncol 2002, 63: 249-255. 10.1016/S0167-8140(01)00469-8CrossRef Fiorino C, Vavassori V, Sanguineti G, et al.: Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability. Radiother and Oncol 2002, 63: 249-255. 10.1016/S0167-8140(01)00469-8CrossRef
48.
go back to reference Foppiano F, Fiorino C, Frezza G, et al.: The impact of contouring uncertainty on rectal 3d dose-volume data: results of a dummy run in a multicenter trial (airopros01-02). Int J Radiat Oncol Biol Phys 2003, 57: 573-579. 10.1016/S0360-3016(03)00659-XCrossRefPubMed Foppiano F, Fiorino C, Frezza G, et al.: The impact of contouring uncertainty on rectal 3d dose-volume data: results of a dummy run in a multicenter trial (airopros01-02). Int J Radiat Oncol Biol Phys 2003, 57: 573-579. 10.1016/S0360-3016(03)00659-XCrossRefPubMed
Metadata
Title
Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning
Authors
Lucia Perna
Cesare Cozzarini
Eleonora Maggiulli
Gianni Fellin
Tiziana Rancati
Riccardo Valdagni
Vittorio Vavassori
Sergio Villa
Claudio Fiorino
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2011
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-6-123

Other articles of this Issue 1/2011

Radiation Oncology 1/2011 Go to the issue